KODIFORM THERAPEUTICS LIMITED
CopyKey Data
Status
Company No.
Incorporation date
Size
Contacts
Registered address
Total Assets
No recordsNumber of employees
No recordsCash in Bank
No recordsConfirmation
Accounts
Financial Ratios
No financial ratios available
This company has not submitted financial statements or the data is not publicly available. Please check back later – the information may be updated.
People
Officers
Persons with Significant Control
Similar companies
Category:
Post-harvest crop activitiesComp. code:
03185729Reg. date:
15/04/1996Turnover:
-No. of employees:
-Category:
Silviculture and other forestry activitiesComp. code:
12543378Reg. date:
01/04/2020Turnover:
-No. of employees:
-Category:
Mixed farmingComp. code:
SC127217Reg. date:
12/09/1990Turnover:
-No. of employees:
-Category:
Growing of other non-perennial cropsComp. code:
SC278017Reg. date:
06/01/2005Turnover:
-No. of employees:
-Category:
Mixed farmingComp. code:
02153348Reg. date:
07/08/1987Turnover:
-No. of employees:
-Description
About KODIFORM THERAPEUTICS LIMITED
KODIFORM THERAPEUTICS LIMITED is an(a) Active company incorporated on 05/01/2024 with the registered office located at Scale Space Building C Scale Space Building C, 58 Wood Lane, London W12 7RZ. There are currently 7 active directors according to the latest confirmation statement. Number of employees Unknown according to last financial statements.Frequently Asked Questions
What is the current status of KODIFORM THERAPEUTICS LIMITED?
KODIFORM THERAPEUTICS LIMITED is currently Active. It was registered on 05/01/2024 .
Where is KODIFORM THERAPEUTICS LIMITED located?
KODIFORM THERAPEUTICS LIMITED is registered at Scale Space Building C Scale Space Building C, 58 Wood Lane, London W12 7RZ.
What does KODIFORM THERAPEUTICS LIMITED do?
KODIFORM THERAPEUTICS LIMITED operates in the Research and experimental development on biotechnology (72.11 - SIC 2007) sector.
What is the latest filing for KODIFORM THERAPEUTICS LIMITED?
The latest filing was on 17/03/2026: Appointment of Dr Thorsten Nowak as a director on 2026-02-11.